GSK3B and ischemic stroke: In conclusion, the present report is the first which demonstrates that pre-treatment of a rat model of ischemic stroke with AGNHW for 7 consecutive days effectively curtailed the injury done in the ischemic brain via activation of GSK-3β-mediated HO-1 pathway.